Newborn Screening of Primary Carnitine Deficiency and Prenatal Genetic Diagnosis for a Recurrence‐Risk Family
Molecular Genetics & Genomic Medicine · 2026
DOI: 10.1002/mgg3.70316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Huilin Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Genetics, Yancheng Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Yancheng, China. Hauptthemen laut MEDLINE: Carnitine, Neonatal Screening, Muscular Diseases, Hyperammonemia. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yancheng Science and Technology Bureau, Jiangsu Vocational College of Medicine Collaborative Innovation Research Project between School and Campus, Jiangsu Province Youth Science and Technology Talent Support Project.
Abstract (Originalsprache)
Background
Primary carnitine deficiency (PCD) is a treatable autosomal recessive disorder caused by SLC22A5 gene variants and included in newborn screening widely. However, its prevalence and variant spectrum vary greatly, and prenatal diagnosis for recurrence‐risk families remains rare. This study assessed tandem mass spectrometry (MS/MS) combined with genetic testing in NBS and prenatal diagnosis of PCD in Yancheng, China, and described the local prevalence and variant characteristics.
Methods
From 2015 to 2024, free carnitine (C0) levels were measured in neonatal dried blood spot (DBS) samples by MS/MS for PCD screening. Newborns with persistently low C0 levels were recalled for diagnostic evaluation. At diagnosis, the C0 levels in both neonatal and maternal blood were measured, and next‐generation sequencing was performed for SLC22A5 variants in the newborns. For the recurrence‐risk family with a previous proband, Sanger sequencing was used to confirm the parental origin of the proband's variants, and prenatal diagnosis with amniotic fluid was performed in the subsequent pregnancy.
Results
Combined MS/MS and genetic testing led to the diagnosis of 17 newborns with PCD (15 molecularly confirmed with biochemical results, two clinically inferred) and three newborns with maternal carnitine deficiency among the 152 newborns with persistently low C0 levels on re‐screening. In these 17 PCD newborns, 10 distinct variant sites were detected, of which missense variants predominated, with c.1400C>G (p.S467C) being the most frequent (13/32, 40.63%). For the proband in this recurrence‐risk family, the two pathogenic variants were inherited from each parent. The fetus carried only the maternal variant, without postnatal anomalies.
Conclusion
NBS using MS/MS combined with genetic testing facilitates early diagnosis and classification of PCD. The screening‐detected prevalence of PCD in Yancheng was 1:25,852, with c.1400C>G (p.S467C) as the hotspot variant. Genetic testing of SLC22A5 provided effective prenatal diagnosis for the recurrence‐risk family.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Medical Genetics, Yancheng Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Yancheng, China.
- Pediatric Genetic Metabolic Endocrine Clinic, Yancheng Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Yancheng, China.
- Office for Newborn Disease Screening, Yancheng Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Yancheng, China.
- Department of Neonatology, Yancheng Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Yancheng, China.
ORCID-Profile: Huilin Sun
Förderung
- Yancheng Science and Technology Bureau
- Jiangsu Vocational College of Medicine Collaborative Innovation Research Project between School and Campus
- Jiangsu Province Youth Science and Technology Talent Support Project
Zitieren
APA
Sun, H., Zheng, J., Zhou, C., Chen, H., Zhang, L., Li, X., Bao, D., Yang, F., & Liu, J. (2026). Newborn Screening of Primary Carnitine Deficiency and Prenatal Genetic Diagnosis for a Recurrence‐Risk Family. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70316
Vancouver
Sun H, Zheng J, Zhou C, Chen H, Zhang L, Li X, et al. Newborn Screening of Primary Carnitine Deficiency and Prenatal Genetic Diagnosis for a Recurrence‐Risk Family. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70316
BibTeX
@article{Sun2026,
author = {Sun, Huilin and Zheng, Jianli and Zhou, Chong and Chen, Haihong and Zhang, Lu and Li, Xiaorui and Bao, Daocheng and Yang, Fangfang and Liu, Jianbing},
title = {Newborn Screening of Primary Carnitine Deficiency and Prenatal Genetic Diagnosis for a Recurrence‐Risk Family},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
doi = {10.1002/mgg3.70316}
}
EUVIMED